Researchers developed SAMP-Score, a machine learning tool that uses cell image morphology to screen for compounds inducing senescence in p16-positive cancer cells.
Key Details
- 1SAMP-Score leverages high-content microscopy images and morphological profiles (SAMPs) to classify cell senescence.
- 2The system screened over 10,000 compounds in p16-positive basal-like breast cancer (BLBC) cells.
- 3It identified QM5928 as a compound that consistently induced cancer cell senescence without killing normal cells.
- 4QM5928 was effective even in cancers resistant to drugs like palbociclib, which are often problematic in high p16-expressing cancers.
- 5The study demonstrates SAMP-Score's ability to detect nuanced morphological changes via AI analysis.
- 6SAMP-Score is openly available to the research community on GitHub.
Why It Matters
This study highlights how AI-driven image analysis can identify promising new drug candidates by detecting subtle cellular changes that traditional methods might miss. Such advances could accelerate development of therapies, particularly for cancers that lack clear biomarkers and respond poorly to existing treatments.
Source
EurekAlert
Related News
•EurekAlert
MSKAI Unveils AI Tool for Embryo Cell Analysis and Imaging-Driven Cancer Insights
MSK researchers employ AI and advanced imaging to reveal cancer mechanisms and track embryonic development at the single-cell level.
•EurekAlert
AI-Driven Home Sensors Enable Privacy-Preserving Health Emergency Detection
Researchers have developed an AI-powered home monitoring system using radar and thermal sensors to detect health emergencies and support elderly independent living.
•EurekAlert
New Study Urges 'Green AI' Practices in Medical Imaging and Healthcare
A new review highlights the urgent need for sustainable AI practices in healthcare, with emphasis on environmental impacts from applications like medical imaging.